Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Hui Lei
R & D Center, Luye Pharma Group Ltd.
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
87
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Discovery of Novel, Potent Polo-Like Kinase 1 (PLK1) Inhibitors for the Treatment of Colorectal Cancer
Number of pages: 30
Posted: 03 Feb 2023
Jing Lu
, Hui Lei,
Xinfa Bai
,
Wenyan Wang
,
Chunjiao Liu
,
Yifei Yang
,
Fangxia Zou
,
Guangying Du
,
Xin Wang
,
Cuicui Sun
,
Lisha Yu
,
Mingxu Ma
,
Liang Ye
,
Hongbo Wang
,
Jingwei Tian
and
jianzhao zhang
Yantai University, R & D Center, Luye Pharma Group Ltd., R & D Center, Luye Pharma Group Ltd., Yantai University, Yantai University, Yantai University, Yantai University, Yantai University, Yantai University, R & D Center, Luye Pharma Group Ltd., R & D Center, Luye Pharma Group Ltd., Yantai University, Binzhou Medical University, Yantai University, Yantai University and Yantai University
Downloads
87
(783,685)
View PDF
Download
Abstract:
colorectal cancer, PLK1 inhibitor, Core scaffold hopping, structure-activity relationship
Feedback
